Evidence map›Paper›PMID 40352206›Full record

ArticleNarra J2025

Evaluation of an

Sitti Nurisyah, Mitsuhiro Iyori, Ammar A Hasyim, Khaeriah Amru, Kei Itani, Kurumi Nakamura, Kartika H Zainal, Handayani Halik, Irawaty Djaharuddin, Agussalim Bukhari and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Narra J, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sitti NurisyahDepartment of Pulmonology and Respiratory Medicine, Universitas Hasanuddin, Makassar, Indonesia.
Mitsuhiro IyoriResearch Institute of Pharmaceutical Science, Musashino University, Nishitokyo, Japan.
Ammar A HasyimLaboratory of Vaccinology and Applied Immunology, Kanazawa University, Ishikawa, Japan.
Khaeriah AmruDr. Tadjuddin Chalid Hospital, Makassar, Indonesia.
Kei ItaniLaboratory of Vaccinology and Applied Immunology, Kanazawa University, Ishikawa, Japan.
Kurumi NakamuraLaboratory of Vaccinology and Applied Immunology, Kanazawa University, Ishikawa, Japan.
Kartika H ZainalLaboratory of Vaccinology and Applied Immunology, Kanazawa University, Ishikawa, Japan.
Handayani HalikUniversitas Megarezky, Makassar, Indonesia.
Irawaty DjaharuddinDepartment of Pulmonology and Respiratory Medicine, Universitas Hasanuddin, Makassar, Indonesia.
Agussalim BukhariDepartment of Clinical Nutrition, Universitas Hasanuddin, Makassar, Indonesia.
Puji Bs AsihNational Research and Innovation Agency, Jakarta, Indonesia.
Din SyafruddinDepartment of Parasitology, Universitas Hasanuddin, Makassar, Indonesia.
Shigeto YoshidaLaboratory of Vaccinology and Applied Immunology, Kanazawa University, Ishikawa, Japan.
Irfan IdrisDepartment of Physiology, Universitas Hasanuddin, Makassar, Indonesia.
Yenni YusufDepartment of Parasitology, Universitas Hasanuddin, Makassar, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evaluating long-term immunity after COVID-19 infection and vaccination is critical for managing potential outbreaks. The aim of this study was to develop a cost-effective in-house enzyme-linked immunosorbent assay (ELISA) based on

Indexed as

Antibodies, ViralCOVID-19COVID-19 Serological TestingCOVID-19 VaccinesSARS-CoV-2Spike Glycoprotein, CoronavirusAdultEnzyme-Linked Immunosorbent AssayEscherichia coliFemaleHumansMaleMiddle AgedVaccinationAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2antibody detectionCapture antigenCOVID-19E. coli expression systemELISA

Identifiers

PMID40352206
PMCPMC12059849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.